Synthetic Biologics, Inc. (AEN) Reports Year End 2012 Financial Results  
4/16/2013 6:43:17 AM

ROCKVILLE, Md., April 16, 2013 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics focused on the prevention and treatment of serious infectious diseases, today reported financial results for the year ended December 31, 2012 and summarized recent operational highlights.